RÉSUMÉ
SUMMARY Hyperreninemic hypoaldosteronism due to aldosterone synthase (AS) deficiency is a rare condition typically presenting as salt-wasting syndrome in the neonatal period. A one-month-old Portuguese boy born to non-consanguineous parents was examined for feeding difficulties and poor weight gain. A laboratory workup revealed severe hyponatremia, hyperkaliaemia and high plasma renin with unappropriated normal plasma aldosterone levels, raising the suspicion of AS deficiency. Genetic analysis showed double homozygous of two different mutations in the CYP11B2 gene: p.Glu198Asp in exon 3 and p.Val386Ala in exon 7. The patient maintains regular follow-up visits in endocrinology clinics and has demonstrated a favourable clinical and laboratory response to mineralocorticoid therapy. To our knowledge, this is the first Portuguese case of AS deficiency reported with confirmed genetic analysis.
Sujet(s)
Humains , Mâle , Nouveau-né , Fludrocortisone/administration et posologie , Hypoaldostéronisme/congénital , Chlorure de sodium/administration et posologie , Cytochrome P-450 CYP11B2/déficit , Hypoaldostéronisme/diagnostic , Hypoaldostéronisme/traitement médicamenteuxRÉSUMÉ
ABSTRACT Hyporeninemic hypoaldosteronism, despite being common, remains an underdiagnosed entity that is more prevalent in patients with diabetes mellitus. It presents with asymptomatic hyperkalemia along with hyperchloraemic metabolic acidosis without significant renal function impairment. The underlying pathophysiological mechanism is not fully understood, but it is postulated that either aldosterone deficiency (hyporeninemic hypoaldosteronism) and/or target organ aldosterone resistance (pseudohypoaldosteronism) may be responsible. Diagnosis is based on laboratory parameters. Treatment strategy varies according to the underlying pathophysiological mechanism and etiology and aims to normalize serum potassium. Two clínical cases are reported and the relevant literature is revisited.
RESUMO Apesar de comum, o hipoaldosteronismo hiporeninêmico continua a ser uma entidade sub-diagnosticada, com maior prevalência em pacientes com diabetes mellitus. A doença cursa com hipercalemia assintomática acompanhada de acidose metabólica hiperclorêmica sem disfunção renal significativa. O mecanismo fisiopatológico subjacente não é entendido em sua totalidade, mas postula-se que a deficiência de aldosterona (hipoaldosteronismo hiporeninêmico) e/ou a resistência à aldosterona no órgão-alvo (pseudo-hipoaldosteronismo) possam ser responsáveis. O diagnóstico é fundamentado em parâmetros laboratoriais. A estratégia terapêutica varia de acordo com o mecanismo fisiopatológico subjacente e a etiologia, mas seu objetivo é normalizar o potássio sérico. O presente artigo relata dois casos e analisa a literatura relevante sobre o assunto.
Sujet(s)
Humains , Mâle , Adulte d'âge moyen , Hypoaldostéronisme/diagnostic , Complications du diabète/diagnostic , Hyperkaliémie/diagnostic , Hypoaldostéronisme/complications , Hyperkaliémie/complicationsRÉSUMÉ
Recently, some genetic forms of hypertension have been well characterized. These forms can be globally called mineralocorticoid hypertension and are due to different alterations of the renin-angiotensin-aldosterone system (SRAA). Among these, classic primary hyperaldosteronism and its glucocorticoid remediable variety, in which hypertension is secondary to aldosterone production, must be considered. There are also conditions in which mineralocorticoid activity does not depend on aldosterone production. These conditions generate a hyporeninemic hyperaldosteronism, observed in Liddle syndrome, apparent mineralocorticoid hypertension, 11- and 17-hydroxilase deficiency, among others. The detection of these forms of hypertension is only feasible if the renin-angiotensin-aldosterone system is assessed, measuring renin and aldosterone levels. This article reviews these forms of hypertension, their clinical workup and their relevance in the usual hypertensive patients
Sujet(s)
Humains , Hypoaldostéronisme/complications , Hyperaldostéronisme/complications , Hypertension artérielle/étiologie , Hypoaldostéronisme/diagnostic , Rénine/métabolisme , Aldostérone/métabolisme , Hyperaldostéronisme/diagnostic , Minéralocorticoïdes/effets indésirables , Minéralocorticoïdes , Marqueurs biologiquesRÉSUMÉ
El hipoaldosteronismo hiporreninémico es un síndrome que no es infrecuente en la práctica clínica, pero que indudablemente es subdiagnosticado. Constituye la mitad de los casos de hiperkalemia inexplicada, por lo que es un diagnóstico que siempre debe tenerse presente, sobre todo en pacientes diabéticos con algún grado de insuficiencia renal. El diagnóstico se confirma con la medición de aldosterona plasmática y la actividad de renina plasmática, en presencia de una función glucocorticoidea normal. Se presenta un caso clínico de hipoaldosteronismo hiporreninémico, cuyo diagnóstico fue sospechado a través de una hiperkalemia asintomática de etiología inexplicada, el que fue confirmado por los exámenes pertinentes y cuyo tratamiento con diuréticos resultó exitoso